Reviewed,
UniProtKB/Swiss-Prot P17181 (INAR1_HUMAN)
Last modified
June 16, 2009.
Version 89.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Interferon-alpha/beta receptor alpha chain Short name=IFN-alpha-REC | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 557 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Receptor for interferons alpha and beta. Binding to type I IFNs triggers tyrosine phosphorylation of a number of proteins including JAKs, TYK2, STAT proteins and IFNR alpha- and beta-subunits themselves. |
| Subcellular location | Isoform 1: Membrane; Single-pass type I membrane protein. |
| Tissue specificity | IFN receptors are present in all tissues and even on the surface of most IFN-resistant cells. Isoform 1, isoform 2 and isoform 3 are expressed in the IFN-alpha sensitive myeloma cell line U266S. Isoform 2 and isoform 3 are expressed in the IFN-alpha resistant myeloma cell line U266R, isoform 1 is not expressed in U266R. Ref.6 |
| Post-translational modification | Phosphorylated on tyrosine residues by TYK2 tyrosine kinase. Ref.7 |
| Sequence similarities | Belongs to the type II cytokine receptor family. Contains 3 fibronectin type-III domains. |
| Sequence caution | The sequence AAH02590.1 differs from that shown. Reason: Miscellaneous discrepancy. Contaminating sequence. Potential poly-A sequence. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Repeat Signal Transmembrane |
| Molecular function | Receptor |
| PTM | Disulfide bond Glycoprotein Phosphoprotein |
| Gene Ontology (GO) | |
| Biological process | JAK-STAT cascade Traceable author statement. Source: ProtInc cell surface receptor linked signal transductionTraceable author statement. Source: ProtInc response to virus Ref.1Traceable author statement. Source: ProtInc |
| Cellular component | integral to plasma membrane Traceable author statement. Source: ProtInc |
| Molecular function | type I interferon receptor activity Traceable author statement. Source: ProtInc |
| Complete GO annotation... | |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P17181-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P17181-2) Also known as: Sol-1; Soluble form 1; The sequence of this isoform differs from the canonical sequence as follows: 428-434: KTKPGNT → NISLNSH 435-557: Missing. | ||||||
| Note: Incomplete sequence. | ||||||
| Isoform 3 (identifier: P17181-3) Also known as: Sol-2; Soluble form 2; The sequence of this isoform differs from the canonical sequence as follows: 414-421: Missing. 428-480: Missing. | ||||||
| Note: Incomplete sequence. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 27 | 27 | Potential | ||||||||
| Chain | 28 – 557 | 530 | Interferon-alpha/beta receptor alpha chain | PRO_0000011001 | |||||||
Regions | |||||||||||
| Topological domain | 28 – 436 | 409 | Extracellular Potential | ||||||||
| Transmembrane | 437 – 457 | 21 | Potential | ||||||||
| Topological domain | 458 – 557 | 100 | Cytoplasmic Potential | ||||||||
| Domain | 134 – 224 | 91 | Fibronectin type-III 1 | ||||||||
| Domain | 230 – 326 | 97 | Fibronectin type-III 2 | ||||||||
| Domain | 334 – 425 | 92 | Fibronectin type-III 3 | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 466 | 1 | Phosphotyrosine; by TYK2 Probable | ||||||||
| Modified residue | 481 | 1 | Phosphotyrosine; by TYK2 Probable | ||||||||
| Glycosylation | 50 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 58 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 81 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 88 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 110 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 172 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 254 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 313 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 314 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 376 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 416 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 433 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 79 ↔ 87 | By similarity | |||||||||
| Disulfide bond | 199 ↔ 220 | By similarity | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 414 – 421 | 8 | Missing in isoform 3. | VSP_029928 | |||||||
| Alternative sequence | 428 – 480 | 53 | Missing in isoform 3. | VSP_029929 | |||||||
| Alternative sequence | 428 – 434 | 7 | KTKPGNT → NISLNSH in isoform 2. | VSP_029930 | |||||||
| Alternative sequence | 435 – 557 | 123 | Missing in isoform 2. | VSP_029931 | |||||||
| Natural variant | 168 | 1 | V → L: dbSNP rs2257167. Ref.1 Ref.2 Ref.3 | VAR_002717 | |||||||
| Natural variant | 307 | 1 | V → I: dbSNP rs17875833. Ref.4 | VAR_020502 | |||||||
| Natural variant | 359 | 1 | T → M: dbSNP rs17875834. Ref.4 | VAR_020503 | |||||||
Experimental info | |||||||||||
| Sequence conflict | 17 | 1 | A → G in AAA52730. Ref.1 | ||||||||
| Sequence conflict | 59 | 1 | V → M in BAD96532. Ref.3 | ||||||||
| Sequence conflict | 279 | 1 | Q → R in BAD96532. Ref.3 | ||||||||
| Sequence conflict | 479 | 1 | D → N in BAD96532. Ref.3 | ||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA." Uze G., Lutfalla G., Gresser I. Cell 60:225-234(1990) [PubMed: 2153461] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT LEU-168. |
| [2] | "The structure of the human interferon alpha/beta receptor gene." Lutfalla G., Gardiner K., Proudhon D., Vielh E., Uze G. J. Biol. Chem. 267:2802-2809(1992) [PubMed: 1370833] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT LEU-168. |
| [3] | Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S. Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT LEU-168. Tissue: Liver. |
| [4] | SeattleSNPs variation discovery resource Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS ILE-307 AND MET-359. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Brain and Ovary. |
| [6] | "Identification of mRNAs encoding two different soluble forms of the human interferon alpha-receptor." Abramovich C., Ratovitski E., Lundgren E., Revel M. FEBS Lett. 338:295-300(1994) [PubMed: 8307198] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 398-514 (ISOFORM 3) AND 419-557 (ISOFORM 2), TISSUE SPECIFICITY, ALTERNATIVE SPLICING. Tissue: Myeloma. |
| [7] | "Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase." Colamonici O., Yan H., Domanski P., Handa R., Smalley D., Mullersman J., Witte M., Krishnan K., Krolewski J. Mol. Cell. Biol. 14:8133-8142(1994) [PubMed: 7526154] [Abstract] Cited for: PHOSPHORYLATION BY TYK2. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| J03171 mRNA. Translation: AAA52730.1. X60459 Genomic DNA. Translation: CAA42992.1. AK222770 mRNA. Translation: BAD96490.1. AK222812 mRNA. Translation: BAD96532.1. AY654286 Genomic DNA. Translation: AAT49100.1. BC002590 mRNA. Translation: AAH02590.1. Sequence problems. BC021825 mRNA. Translation: AAH21825.1. | |
| IPI | IPI00012877. IPI00877141. IPI00877162. |
| PIR | A32694. S41602. |
| RefSeq | NP_000620.2. |
| UniGene | Hs.529400 |
3D structure databases | |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP:57N. |
| IntAct | P17181. 1 interaction. |
PTM databases | |
| PhosphoSite | P17181. |
Proteomic databases | |
| PRIDE | P17181. |
Genome annotation databases | |
| Ensembl | ENSG00000142166. Homo sapiens. [Contig view] |
| GeneID | 3454. |
| KEGG | hsa:3454. |
Organism-specific databases | |
| GeneCards | GC21P033619. |
| H-InvDB | HIX0027789. |
| HGNC | HGNC:5432. IFNAR1. |
| HPA | HPA018015. |
| MIM | 107450. gene. |
| PharmGKB | PA29670. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOGENOM | P17181. |
| HOVERGEN | P17181. |
| OMA | P17181. TSFWSEE. |
Enzyme and pathway databases | |
| Pathway_Interaction_DB | cd8tcrdownstreampathway. Downstream signaling in naive CD8+ T cells. |
Gene expression databases | |
| ArrayExpress | P17181. |
| Bgee | P17181. |
| CleanEx | HS_IFNAR1. |
| GermOnline | ENSG00000142166. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR008957. Fibronectin_typ-III-like_fold. IPR003961. FN_III. IPR016669. Interferon_alpha/beta_rcpt-1. [Graphical view] |
| Gene3D | G3DSA:2.60.40.30. FN_III-like. 2 hits. |
| PIRSF | PIRSF016567. IFN_alpha/beta_recept-1. 1 hit. |
| SMART | SM00060. FN3. 4 hits. [Graphical view] |
| PROSITE | PS50853. FN3. False negative. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| DrugBank | DB00034. Interferon Alfa-2a, Recombinant. DB00105. Interferon Alfa-2b, Recombinant. DB00011. Interferon alfa-n1. DB00018. Interferon alfa-n3. DB00069. Interferon alfacon-1. DB00068. Interferon beta-1b. DB00008. Peginterferon alfa-2a. DB00022. Peginterferon alfa-2b. |
| NextBio | 13606. |
| SOURCE | Search... |
Entry information
| Entry name | INAR1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P17181 Secondary accession number(s): Q53GW9 Q8WTZ2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 21 Human chromosome 21: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


